RE: My panic and new drugs

LuAnn Creed (rustyspfd(AT)msn.com)
Mon, 28 Apr 97 02:41:02 UT

The onset description is exactly that of the case I am working on. Recent
exam & evaluation by a rhumatologist has confirmed our suspicions that the
etiology of our patient's TM is Lupus.
I couldn't find the abstract you included. Please give me information so that
we may order the article.
And, yes, I'm still out here, reading and absorbing the information you all
have provided. I'm currently working on a plan to get our patient back into
her home environment while the litigation proceeds. By continuing to read
your thoughts and frustrations, it has helped me to have a better
understanding of the frustration of our patient.

----------
From: DC. Jones
Sent: Thursday, April 24, 1997 9:12 PM
To: tmic-list(AT)eskimo.com
Subject: Re: My panic and new drugs

"My doctor believes that TM in most cases is a rare form of Lupus
(SLE). Lupus by definition is a chronic disorder of the immune system
that causes inflammation of various parts of the body. He also
believes there is an 18 month window of recovery. All that doesn't
return by than probably never will".

>I read this and looked this up in medline; for what it's worth. DCJones<

DATE: 1993 Jun

Abstract

Transverse myelitis has been cited as a rare and unusual complication of
systemic lupus erythematosus (SLE). A review of
the literature reveals only 10 cases of transverse myelitis as the
initial presentation of SLE, and only one with reported
benefits from antimalarial therapy. The case of a 30-year-old woman is
reviewed. She presented to the emergency room with
complaints of hypogastric and low back pain. The ensuing course was one
of frank urinary retention and rapidly progressing
quadriparesis. Magnetic resonance imaging of the spine revealed marked
edema of the cervical and thoracic spine. A diagnosis
of SLE was based on positive antinuclear antibodies and leukopenia. The
patient was treated with high dose
methylprednisolone, plasmapheresis and pulse cyclophosphamide for 3
months. Subsequently, treatment was begun with
hydroxychloroquine, and significant improvement in her neurologic and
functional status was achieved after 1 month of therapy.
Ten months after her onset of symptoms, the patient suffered an acute
exacerbation of paraparesis and urinary retention.
Again, she improved clinically after high dose methylprednisolone and
pulse cyclophosphamide for 1 month.
Hydroxychloroquine was continued throughout the duration of therapy.


Klaiman MD Miller SD